English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Cannabinoid pharmacology has been explored as a therapeutic option for handling pathologies and conditions of varying nature. In regard to neurological disorders, cannabinoid chemistry has been explored for the regulation of hyperkinetic symptoms, anti-inflammation, neuroprotection, and neurodegeneration, a collective goal of many preclinical studies. The enhancement and improvement of the endogenous cannabiner‐ gic responses of the human body in both physiological and pathological conditions, together with the overall consequential effects of the modulation of its elements, are currently under strict scrutiny and undeniably possess incalculable value that might support the hypothesis aiming to improve the endocannabinoid tone with therapeutic purposes. Therefore, this chapter reviews the mechanisms known to be present in the course of several disorders of the basal ganglia, as well as the available treatments exploring this novel approach.

The Potential Therapeutic Role of the Cannabinoid System in Neurological Disorders of the Basal Ganglia: An Overview